Skip to main content
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1986 Mar;21(2):161–163. doi: 10.1007/BF00199865

Effect of dietary polyunsaturated fat and 7,12-dimethylbenz(a)-anthracene on rat splenic natural killer cells and prostaglandin E synthesis

Kam H Leung 1,, Margot M Ip 1
PMCID: PMC11038130  PMID: 3081249

Abstract

Dietary polyunsaturated fat has been shown to stimulate mammary tumorigenesis induced in rats by 7,12-dimethylbenz(a)anthracene (DMBA). Studies were undertaken to investigate the effect of polyunsaturated fat and DMBA on splenic natural killer (NK) activity and prostaglandin E (PGE) synthesis. In a first experiment, splenic NK activity at 33, 55, 75, and 110 days of age was measured in Sprague-Dawley rats fed 0.5% low fat (LF), 5% normal fat (NF), or 20% high fat (HF) corn oil diets from 23 days of age. At 55 days of age, half of the rats from the 75 and 110 day age groups were given 5 mg DMBA. Ten days after the initiation of the diets splenic NK activity against YAC-1 lymphoma was decreased from 50% cytotoxicity in rats fed NF diet to 21% cytotoxicity in rats fed HF diet, but was not affected by LF feeding. No difference in NK activity was observed among the groups at the later time periods. DMBA had no effect on NK activity at 20 or 55 days after its administration. In a second experiment, where DMBA (15 mg/rat) was given to half of the rats at 50 days of age and NF or HF diets were started 3 days later, NK activity was 35% in rats fed NF diet and 21% in rats fed HF diet, 5 days after the diets were started. No difference in NK activity in rats fed either diet was observed at later time periods. DMBA decreased both NK activity and spleen cellularity transiently. In both experiments, PGE synthesis by spleen cells cultured for 18 h was not affected by dietary fat intake, but was slightly increased 3 days after DMBA administration. Results from these experiments suggest that the stimulation of DMBA-induced mammary tumorigenesis by polyunsaturated fat and by DMBA itself may possibly be mediated by a transient decrease in splenic NK cell activity.

Keywords: Anthracene, DMBA, Natural Killer Cell Activity, Natural Killer Activity, Mammary Tumorigenesis

Footnotes

This work was supported by grants CA-35641, CA-33240, CA-13038 and Core Grant CA-24538 from the National Cancer Institute

References

  • 1.Barlozzari T, Reynolds CW, Herberman RB. In vivo role of natural killer cells: involvement of large granular lymphocytes in the clearance of tumor cells in anti-asialo GM1-treated rats. J Immunol. 1983;131:1024–1027. [PubMed] [Google Scholar]
  • 2.Brunda MJ, Herberman RB, Holden H. Inhibition of murine natural killer cell activity by prostaglandin. J Immunol. 1980;124:2682–2687. [PubMed] [Google Scholar]
  • 3.Carter CA, Milholland RJ, Shea W, Ip MM. Effect of the prostaglandin synthetase inhibitor indomethacin on 7,12-dimethylbenz(a)anthracene-induced mammary tumorigenesis in rats fed different levels of fat. Cancer Res. 1983;43:3559–3562. [PubMed] [Google Scholar]
  • 4.Droller M, Shneider MU, Perlmann P. A possible role of prostaglandins in the inhibition of natural and antibody-dependent cell-mediated cytotoxicity against tumor cells. Cell Immunol. 1978;35:165–177. doi: 10.1016/0008-8749(78)90091-6. [DOI] [PubMed] [Google Scholar]
  • 5.Ehrlich R, Efrati M, Ber-Eyal A, Wollberg M, Schilby G, Ran M, Witz IP. Natural cellualr reactivities mediated by splenocytes from mice bearing three types of primary tumor. Int J Cancer. 1980;26:315–323. doi: 10.1002/ijc.2910260310. [DOI] [PubMed] [Google Scholar]
  • 6.Goodwin JS, Ceuppens J. Regulation of the immune response by prostaglandins. J Clin Immunol. 1983;3:295–315. doi: 10.1007/BF00915791. [DOI] [PubMed] [Google Scholar]
  • 7.Gorelik E, Herberman RB. Inhibition of the activity of mouse natural killer cells by urethan. J Natl Cancer Inst. 1981;66:543–548. [PubMed] [Google Scholar]
  • 8.Haller O, Hansson M, Kiessling R, Wigzell H. Role of non-conventinal natural killer cells in resistance against syngeneic tumor cells in vivo. Nature. 1977;270:609–611. doi: 10.1038/270609a0. [DOI] [PubMed] [Google Scholar]
  • 9.Hanna N, Burton RC. Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastasis in vivo. J Immunol. 1981;127:1754–1758. [PubMed] [Google Scholar]
  • 10.Ip C, Sinha D. Neoplastic growth of carcinogen-treated mammary transplants as influenced by fat intake of donor and host. Cancer Lett. 1981;11:277–283. doi: 10.1016/0304-3835(81)90092-6. [DOI] [PubMed] [Google Scholar]
  • 11.Kalland T, Forsberg J-G. 3-Methylcholanthrene: transient inhibition of the lytic step of mouse natural killer cells. J Natl Cancer Inst. 1983;71:385–390. [PubMed] [Google Scholar]
  • 12.Kennedy MS, Stobo JD, Goldyne ME. In vitro synthesis of prostaglandins and related lipids by populations of human peripheral blood monocyttes. Prostaglandins. 1980;20:135–145. doi: 10.1016/0090-6980(80)90013-1. [DOI] [PubMed] [Google Scholar]
  • 13.Leung KH, Koren HS. Regulation of human natural killing II. Protective effect of interferon on NK cells from suppression by PGE2 . J Immunol. 1982;129:1742–1747. [PubMed] [Google Scholar]
  • 14.Leung KH, Mihich E. Effects of prostaglandins on the development of cell-mediated immunity in culture and on the cytolytic activity of in vivo-generated effector cells. Int J Immunopharmacol. 1982;4:205–217. doi: 10.1016/0192-0561(82)90050-9. [DOI] [PubMed] [Google Scholar]
  • 15.Leung KH, Koren HS. Regulation of human natural killing III. Mechanism for interferon induction of loss of susceptibility to suppression by cyclic AMP elevating agents. J Immunol. 1984;132:1445–1450. [PubMed] [Google Scholar]
  • 16.Leung KH, Ip MM. Inhibition of rat natural killer (NK) activity and NK activation by inhibitors of lipoxygenase (LO) and protein synthesis (PS) Fed Proc. 1984;43:663. [Google Scholar]
  • 17.Leung KH, Ehrke MJ, Mihich E. Modulation of the development of cell-mediated immunity: possible role of the products of the cyclo-oxygenase and the lipoxygenase pathways of arachidonic acid metabolism. Int J Immunopharmacol. 1982;4:195–204. doi: 10.1016/0192-0561(82)90049-2. [DOI] [PubMed] [Google Scholar]
  • 18.Leung KH, Fischer DG, Koren HS. Erythromyeloid tumor cells (K562) induce PGE synthesis in human peripheral blood monocytes. J Immunol. 1983;131:445–449. [PubMed] [Google Scholar]
  • 19.Plescia OJ, Grinwich K, Plesica AM. Subversive activity of syngeneic tumor cells as an escape mechanism from immune surveillance and the role of prostaglandins. Ann NY Acad Sci. 1976;276:455–465. doi: 10.1111/j.1749-6632.1976.tb41670.x. [DOI] [PubMed] [Google Scholar]
  • 20.Welsch CW, Aylsworth CF. Enhancement of murine mammary tumorigenesis by feeding high levels of dietary fat: A hormonal mechanism. J Natl Cancer Inst. 1983;70:215–221. [PubMed] [Google Scholar]
  • 21.Kollmorgen GM, King MM, Kosanke SD, Do C. Influence of dietary fat and indomethacin on the growth of transplantable mammary tumors in rats. Cancer Res. 1983;43:4714–19. [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES